AstraZeneca India has declared its entry into the Indian market for rare disease therapy. The regulatory approval of its 'Selumetinib' shows the company's commitment to bringing first-in-class, science-based therapies to patients in India...
Zydus Lifesciences said it has received approval from the US health regulator to market a generic medication to prevent and treat blood clots. The company has received approval from the US Food and Drug Administration (USFDA) to market Apixaban...
The Wall Street Journal reported on Sunday that Pfizer Inc is in early-stage talks to acquire cancer drugmaker Seagen Inc in a multibillion-dollar deal, citing people familiar with the matter...
Medijourn, India's biggest healthcare facilitator and super aggregator in the global medical value travel industry, has announced a partnership with 8chili Inc., a deep-tech start-up based in California that is developing the underlying...
Venus Remedies announced on Monday that it has obtained good manufacturing practises (GMF) certification from the Saudi drug regulator for its Baddi, Himachal Pradesh, production facilities...
Dr Reddy's Laboratories Ltd announced that its subsidiary has entered into a definitive agreement to acquire Australia-based Mayne Pharma Group Limited's US generic prescription product portfolio for USD 105 million. According to a press release...
The US Food and Drug Administration (FDA) has granted an emergency use authorization (EUA) for the first over-the-counter (OTC) at-home diagnostic test capable of distinguishing and detecting influenza A and B, also known as the flu, and...
Track and trace in the pharmaceutical sector are connected to the merits related to the efficiency of the manufacturer & the prevention of the entry of counterfeit drugs.
Government is speaking with stakeholders to discover ambitious projects and define the role of industry in executing its recent budget proposal, which is intended to advance research and innovation in pharmaceutical industry.
ASLAN Pharmaceuticals entered into a definitive purchase agreement with BVF Partners, K2 Health Ventures, and certain existing investors to raise gross proceeds of $20 million through the sale of shares (112.3M shares equivalent to 22.5M ADSs at a...
, CDSCO.jpg)
